Delivery Order SPE2DB22D3011-SPE2DB26FP7FR
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,345.16 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on August 6, 2025, with an ultimate completion date of August 7, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, serves as...
- The Defense Logistics Agency awarded a $7,390.48 delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $47,038.50 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on August 14, 2025, with completion scheduled for August 15, 2025. This firm fixed-price contract represents a competitively awarded, non-set-aside procurement supporting federal medical supply requirements. The award was issued to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, the company's headquarters and primary distribution hub for...
- The Defense Logistics Agency awarded a delivery order valued at $33,522.33 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with completion scheduled for September 2, 2025. The award, issued on August 29, 2025, represents a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,175.66 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of July 23, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The award represents a single transaction under AmerisourceBergen's broader federal contract portfolio supporting military and veteran healthcare procurement needs....
- The Defense Logistics Agency awarded a delivery order valued at $4,356.33 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a $11,180.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of September 26, 2025. This non-set-aside contract was awarded competitively on September 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,925.33 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on September 11, 2025. This is a firm fixed price delivery order with an ultimate completion date of September 12, 2025, and represents performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, consistent with AmerisourceBergen's standard federal procurement...
- The Defense Logistics Agency awarded a delivery order valued at $1,661.70 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of October 23, 2025. This non-set-aside contract utilizes firm fixed pricing under a delivery order contract type and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was competitively...
- The Defense Logistics Agency awarded a delivery order valued at $5,538.90 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of August 5, 2025. This is a firm fixed-price delivery order under a competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical supply vendor that serves military and veteran healthcare systems through the DLA...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB26FP7FRDelivery Order
The Defense Logistics Agency awarded a $17,531.26 delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of October 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and specifies performance at the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical supplier for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order represents a discrete transaction under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The underlying IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceuticals and medical supplies, including vaccines, specialty medications, and medical commodities to support military healthcare programs worldwide. The delivery order award reflects AmerisourceBergen Drug Corp's demonstrated capability to fulfill federal medical supply requirements through open competition and its established role as a preferred vendor within the DLA's pharmaceutical procurement framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.5k | 10/22/25 |